INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,623,171 | +0.5% | 5,054,383 | -16.0% | 0.01% | 0.0% |
| Q2 2023 | $127,034,217 | +17.8% | 6,020,579 | -4.8% | 0.01% | +16.7% |
| Q1 2023 | $107,844,745 | -60.8% | 6,325,205 | -54.1% | 0.01% | -25.0% |
| Q4 2022 | $275,192,012 | +134.4% | 13,773,374 | +152.7% | 0.01% | +14.3% |
| Q3 2022 | $117,424,000 | +2.3% | 5,451,417 | -6.3% | 0.01% | 0.0% |
| Q2 2022 | $114,752,000 | -4.7% | 5,819,072 | +13.6% | 0.01% | +16.7% |
| Q1 2022 | $120,359,000 | +1.5% | 5,121,644 | +17.6% | 0.01% | 0.0% |
| Q4 2021 | $118,597,000 | +3.4% | 4,353,768 | +4.6% | 0.01% | 0.0% |
| Q3 2021 | $114,666,000 | +12.7% | 4,163,613 | +16.5% | 0.01% | +20.0% |
| Q2 2021 | $101,725,000 | -7.5% | 3,574,308 | +10.7% | 0.01% | -16.7% |
| Q1 2021 | $110,017,000 | -8.0% | 3,230,105 | -10.1% | 0.01% | -14.3% |
| Q4 2020 | $119,633,000 | -0.1% | 3,593,670 | -3.6% | 0.01% | -12.5% |
| Q3 2020 | $119,777,000 | +8.2% | 3,726,739 | -7.3% | 0.01% | 0.0% |
| Q2 2020 | $110,734,000 | +99.9% | 4,020,847 | +16.4% | 0.01% | +60.0% |
| Q1 2020 | $55,392,000 | -32.6% | 3,455,490 | +0.4% | 0.01% | -16.7% |
| Q4 2019 | $82,210,000 | +15.0% | 3,442,635 | -15.0% | 0.01% | +20.0% |
| Q3 2019 | $71,463,000 | -12.2% | 4,051,169 | +27.4% | 0.01% | -16.7% |
| Q2 2019 | $81,420,000 | -1.4% | 3,180,476 | +11.9% | 0.01% | 0.0% |
| Q1 2019 | $82,599,000 | +90.0% | 2,841,366 | -14.2% | 0.01% | +50.0% |
| Q4 2018 | $43,463,000 | -40.5% | 3,312,730 | -8.3% | 0.00% | -33.3% |
| Q3 2018 | $73,064,000 | +3.7% | 3,613,559 | +21.3% | 0.01% | 0.0% |
| Q2 2018 | $70,425,000 | -9.6% | 2,977,862 | -14.0% | 0.01% | -14.3% |
| Q1 2018 | $77,944,000 | -14.2% | 3,461,180 | +18.8% | 0.01% | 0.0% |
| Q4 2017 | $90,805,000 | +64.0% | 2,912,319 | +64.1% | 0.01% | +40.0% |
| Q3 2017 | $55,374,000 | +86.8% | 1,774,281 | +2.7% | 0.01% | +66.7% |
| Q2 2017 | $29,651,000 | +12.9% | 1,728,017 | +15.2% | 0.00% | +50.0% |
| Q1 2017 | $26,259,000 | +38.7% | 1,499,611 | +4.8% | 0.00% | 0.0% |
| Q4 2016 | $18,935,000 | -7.8% | 1,431,292 | +1.2% | 0.00% | 0.0% |
| Q3 2016 | $20,535,000 | +53.1% | 1,414,162 | +4.0% | 0.00% | +100.0% |
| Q2 2016 | $13,409,000 | -30.9% | 1,359,861 | -11.2% | 0.00% | -50.0% |
| Q1 2016 | $19,399,000 | -33.8% | 1,531,234 | -5.1% | 0.00% | -33.3% |
| Q4 2015 | $29,298,000 | -19.4% | 1,614,040 | -17.5% | 0.00% | -25.0% |
| Q3 2015 | $36,340,000 | -28.5% | 1,957,007 | -5.9% | 0.00% | -20.0% |
| Q2 2015 | $50,798,000 | +37.5% | 2,080,094 | +17.1% | 0.01% | +25.0% |
| Q1 2015 | $36,952,000 | +25.8% | 1,776,482 | -6.4% | 0.00% | +33.3% |
| Q4 2014 | $29,365,000 | +23.2% | 1,898,115 | +3.9% | 0.00% | 0.0% |
| Q3 2014 | $23,837,000 | -29.4% | 1,826,471 | +8.1% | 0.00% | -25.0% |
| Q2 2014 | $33,761,000 | +21.3% | 1,689,523 | +15.6% | 0.00% | +33.3% |
| Q1 2014 | $27,830,000 | +11.6% | 1,461,978 | -1.3% | 0.00% | +50.0% |
| Q4 2013 | $24,935,000 | +2.2% | 1,480,917 | -5.3% | 0.00% | -33.3% |
| Q3 2013 | $24,400,000 | +487.5% | 1,563,011 | +350.1% | 0.00% | +200.0% |
| Q2 2013 | $4,153,000 | – | 347,288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |